Acupuncture for Frequent Migraine: A Randomized, Patient/Assessor Blinded, Controlled Trial with One-Year Follow-Up
Table 5
Comparisons of demographic variables at baseline.
Variables
RA ()
SA ()
value
Demographic data
Age (years) mean (SD)
41.6 (14.9)
43.8 (13.4)
0.58
Migraine history (years) mean (SD)
18.4 (12.7)
21.1 (13.3)
0.47
Gender (%)
Female
18 (75%)
19 (73.1%)
0.88
Acupuncture experience (%)
No
10 (41.7%)
14 (53.9%)
0.39
Yes
14 (58.3%)
12 (46.1%)
Marital status (%)
Partnered
17 (70.8%)
17 (65.4%)
0.68
Single
7 (29.2%)
9 (34.6%)
Education level ()
H: university or higher
10
12
0.52
S: 9 or more years of formal education
12
14
L: less than 9 years
1
0
M: missing data
1
0
Type of migraine (%)
MO: migraine without aura
16 (32%)
13 (26%)
0.46
MA: migraine with aura
3 (6%)
6 (12%)
Both: MO and MA cooccurrence
5 (10%)
7 (14%)
Outcomes measures#
Migraine days (number of days with migraine per 4 weeks)
11.8 (5.8)
12.4 (6.4)
0.73
Duration (hours /attack)
9.0 (3.6)
8.9 (4.8)
0.91
Highest pain-VAS
6.0 (1.1)
5.3 (2.0)
0.11
Lowest pain-VAS
3.1 (1.8)
2.7 (1.9)
0.39
Average pain-VAS
4.6 (1.4)
4.0 (2.0)
0.21
Severity of pain (six-point Likert scale)
3.2 (0.4)
3.2 (0.6)
0.79
McGill
PRI-S
18.3 (8.9)
21.3 (7.5)
0.20
PRI-A
5.4 (2.7)
6.7 (3.2)
0.14
PRI-E
3.5 (1.3)
3.6 (1.1)
0.73
PRI-M
6.7 (3.0)
7.6 (3.2)
0.34
Total
33.9 (13.4)
39.0 (13.2)
0.19
MSQOL
FR
54.2 (17.2)
46.7 (18.9)
0.15
FP
71.0 (19.0)
61.7 (20.6)
0.10
EF
54.7 (24.8)
48.5 (24.2)
0.40
Medication
MQS
93.8 (81.1)
87.0 (110.2)
0.81
Pill count
13.50 (20.27)
7.27 (13.50)
0.54
Number of participants who took pain killers
22
23
0.71
Number of participants who took specific antimigraine drugs
4
3
0.60
Number of participants who took prophylactic drugs
12
11
0.59
RA: real acupuncture group; SA: sham acupuncture group; #Clinical data were summarized as mean (SD); PRI-S: sensory components; PRI-A: affective components; PRI-E: evaluative components; PRI-M: miscellaneous components; FR: function-restrictive in Migraine Specific Quality of Life questionnaire; FP: function-preventive in Migraine Specific Quality of Life questionnaire; EF: emotional function in Migraine Specific Quality of Life questionnaire; PPT: pressure pain threshold; MQS: Medication Quantification Scale.
